Close Menu

NEW YORK – The Blood Profiling Atlas in Cancer Consortium (BloodPAC) has released a series of analytical protocols for validating next-generation sequencing (NGS)-based circulating tumor DNA (ctDNA) assays, which the consortium believes will help accelerate the development and regulatory reviews of new tests.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.